Plasmafabriek Sanquin

GammaQuin

To treat immunodeficiency disorders without a known cause and to prevent hepatitis A

Description

GammaQuin is used to treat immunodeficiency disorders without a known cause and to prevent hepatitis A

GammaQuin is used for hereditary (congenital) or acquired immunodeficiency disorders without a known cause, whereby regular infections occur. Through treatment using GammaQuin infections can be prevented or treated.

Product information

GammaQuin is no longer available in product presentations of 5 ml and 15 ml. These could be used as substitution therapy in the case of immunodeficiency diseases. Various registered preparations are available as alternatives for this group of patients.

GammaQuin is still available in presentations of 2 ml. However, these are only provided to prevent symptoms of hepatitis A and measles, therefore, not as a replacement for GammaQuin 5 and 15 ml. GammaQuin 2 ml can only be ordered directly from Sanquin, not via the wholesale sector. Since November 2018, GammaQuin has no longer been available in presentations of 1 ml.

  • When is GammaQuin used?

    GammaQuin is used for hereditary (congenital) or acquired immunodeficiency disorders without a known cause, whereby regular infections occur. Through treatment using GammaQuin infections can be prevented or treated.

    GammaQuin is also used to prevent or moderate hepatitis A.

    GammaQuin is also used to prevent measles or to reduce the symptoms of the illness.
    Read more in the GammaQuin leaflet (pdf).

  • How is GammaQuin used?

    GammaQuin is a solution for an injection.

    To treat an immunodeficiency disorder, a subcutaneous injection of GammaQuin can be administered.

    To prevent a hepatitis A infection and measles, an intramuscular injection of GammaQuin can be administered. 

  • What dosage of GammaQuin is administered?

    The physician specifies the dosage of GammaQuin. The quantity of GammaQuin required depends on the reason the patient is receiving GammaQuin.

  • How is GammaQuin administered?

    To prevent hepatitis A, the medical practitioner administers an intramuscular injection of GammaQuin. This is slowly injected into the patient’s upper arm or buttock. If more than 5 ml is required, the dosage should be distributed over multiple injection spots.

    Larger quantities of GammaQuin are required to treat immunodeficiency disorders. These can be administered via a subcutaneous infusion pump containing GammaQuin. It is also possible to administer the quantity of GammaQuin over several injection sites.

    • Remove the vial from the refrigerator and allow it to reach room temperature.
    • It is a clear solution.
    • During the period of storage, slight turbidity or a small amount of precipitation may occur. This will not affect the efficacy of the product.
    • Dependent on the dosage, more than one vial may be used. 
    • The content of several vials can be mixed for administration to the patient.
    • The product should be suctioned into a sterile syringe.
  • What are the side effects of GammaQuin?

    GammaQuin can cause side effects, in the same way as all other medicines. The patient may feel some pain or sensitivity at the site of the injection.

    Rarely
    Very rarely the patient could develop a fever and/or a skin rash. Side effects include nausea, vomiting, low blood pressure, a rapid heartbeat and hypersensitivity reactions.   
     

  • How is GammaQuin stored?

    • out of reach and sight of children
    • in the refrigerator at 2 - 8 °C (therefore, do not freeze)
    • in the original packaging to protect it from the light


    Not to be used after the expiry date
    Do not use GammaQuin after its expiry date. This is stipulated on the label (on the vial) and on the box.

    Disposal
    Patients can hand any used medicines over to a pharmacy. By not disposing of medicines via waste water or household waste, we are helping to protect the environment.

    Read more in the GammaQuin leaflet (pdf).